Literature DB >> 9413101

Immunization of cattle with a BHV1 vector vaccine or a DNA vaccine both coding for the G protein of BRSV.

R S Schrijver1, J P Langedijk, G M Keil, W G Middel, M Maris-Veldhuis, J T Van Oirschot, F A Rijsewijk.   

Abstract

A gE-negative bovine herpesvirus 1 (BHV1) vector vaccine carrying a gene coding for the G protein of bovine respiratory syncytial virus (BRSV) (BHV1/BRSV-G) induced the same high degree of protection in calves against BRSV infection and BHV1 infection as a multivalent commercial vaccine. A DNA plasmid vaccine, carrying the same gene as the BHV1/BRSV-G vaccine, significantly reduced BRSV shedding after BRSV infection compared with that in control calves, but less well than the BHV1/BRSV-G vaccine. Flow cytometric analysis showed a significant relative increase of gamma/delta+ T cells in peripheral blood after BRSV challenge-infection of the calves of the control group but not in the vaccinated groups. These results indicate that the G protein of BRSV can induce significant protection against BRSV infection in cattle, and that the BHV1/BRSV-G vaccine protects effectively against a subsequent BRSV and BHV1 infection.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9413101     DOI: 10.1016/s0264-410x(97)00129-1

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  10 in total

Review 1.  DNA-antiviral vaccines: new developments and approaches--a review.

Authors:  M Giese
Journal:  Virus Genes       Date:  1998       Impact factor: 2.332

2.  gammadelta(+) T-Lp6phocyte cytotoxicity against envelope-expressing target cells is unique to the alymphocytic state of bovine leukemia virus infection in the natural host.

Authors:  P Lundberg; G A Splitter
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

3.  Targeting improves the efficacy of a DNA vaccine against Corynebacterium pseudotuberculosis in sheep.

Authors:  P J Chaplin; R De Rose; J S Boyle; P McWaters; J Kelly; J M Tennent; A M Lew; J P Scheerlinck
Journal:  Infect Immun       Date:  1999-12       Impact factor: 3.441

4.  Gene gun-mediated DNA immunization primes development of mucosal immunity against bovine herpesvirus 1 in cattle.

Authors:  B I Loehr; P Willson; L A Babiuk
Journal:  J Virol       Date:  2000-07       Impact factor: 5.103

Review 5.  Bovine respiratory syncytial virus (BRSV): a review.

Authors:  L E Larsen
Journal:  Acta Vet Scand       Date:  2000       Impact factor: 1.695

6.  A Novel Rabies Vaccine Based on a Recombinant Bovine Herpes Virus Type 1 Expressing Rabies Virus Glycoprotein.

Authors:  Caiquan Zhao; Jie Gao; Yongzhi Wang; Lina Ji; Hui Qin; Wei Hu; Yang Yang
Journal:  Front Microbiol       Date:  2022-06-08       Impact factor: 6.064

7.  Efficacy of mucosal polyanhydride nanovaccine against respiratory syncytial virus infection in the neonatal calf.

Authors:  Jodi L McGill; Sean M Kelly; Pankaj Kumar; Savannah Speckhart; Shannon L Haughney; Jamie Henningson; Balaji Narasimhan; Randy E Sacco
Journal:  Sci Rep       Date:  2018-02-14       Impact factor: 4.379

Review 8.  A Review of UK-Registered and Candidate Vaccines for Bovine Respiratory Disease.

Authors:  Joanne L Lemon; Michael J McMenamy
Journal:  Vaccines (Basel)       Date:  2021-11-27

9.  Characterization of an experimental vaccine for bovine respiratory syncytial virus.

Authors:  Sara Hägglund; Kefei Hu; Krister Blodörn; Boby Makabi-Panzu; Anne-Laure Gaillard; Karin Ellencrona; Didier Chevret; Lars Hellman; Karin Lövgren Bengtsson; Sabine Riffault; Geraldine Taylor; Jean François Valarcher; Jean-François Eléouët
Journal:  Clin Vaccine Immunol       Date:  2014-05-14

10.  Vaccination of calves using the BRSV nucleocapsid protein in a DNA prime-protein boost strategy stimulates cell-mediated immunity and protects the lungs against BRSV replication and pathology.

Authors:  Carine Letellier; Mathieu Boxus; Laurent Rosar; Jean-François Toussaint; Karl Walravens; Stefan Roels; Gilles Meyer; Jean-Jacques Letesson; Pierre Kerkhofs
Journal:  Vaccine       Date:  2008-07-21       Impact factor: 3.641

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.